Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAPKAPK2 | P49137 | 1/20 | 0.34 |
| ▸ | NOS3 | P29474 | 1/20 | 0.33 |
| ▸ | NOS2 | P35228 | 1/20 | 0.33 |
| ▸ | S1PR4 | O95977 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29419867 | 1.00 | MAPKAPK2 (0.34) | MAPKAPK2NOS3NOS2S1PR4 | |
| SCHEMBL16548309 | 0.85 | NOS3 (0.36) | MAPKAPK2NOS3NOS2 | |
| SCHEMBL28250244 | 0.83 | S1PR4 (0.31) | S1PR4 | |
| SCHEMBL1426102 | 0.82 | NOS3 (0.33) | MAPKAPK2NOS3NOS2S1PR4 | |
| SCHEMBL29693595 | 0.81 | NOS3 (0.35) | NOS3NOS2 | |
| SCHEMBL162396 | 0.81 | NOS3 (0.35) | NOS3NOS2 | |
| SCHEMBL251411 | 0.81 | MAPKAPK2 (0.36) | MAPKAPK2NOS3NOS2 | |
| SCHEMBL28865673 | 0.79 | USP2 (0.42) | — | |
| SCHEMBL29364954 | 0.79 | KDM4E (0.34) | MAPKAPK2S1PR4 | |
| SCHEMBL160005 | 0.79 | KDM4E (0.34) | MAPKAPK2S1PR4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 258 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-04-09 | — | — | US | claimed |
| US-20260096585-A1 | ORAL COMPOSITION | KAO CORPORATION (JP) | 2026-04-09 | — | — | US | claimed |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | VOYAGE FOODS INC (US) | 2026-01-08 | — | — | US | claimed |
| EP-4672982-A1 | PROCESS FOR PREPARING A FLAVOR COMPOSITION | Firmenich SA (CH) | 2026-01-07 | — | — | EP | claimed |
| EP-4606226-A2 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-08-27 | — | — | EP | claimed |
| EP-4591720-A1 | ORAL COMPOSITION | Kao Corporation (JP) | 2025-07-30 | — | — | EP | claimed |
| EP-4578292-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | Voyage Foods, Inc. (US) | 2025-07-02 | — | — | EP | claimed |
| CN-119947594-A | Oral composition | 花王株式会社 | 2025-05-06 | — | — | CN | claimed |
| CN-119931891-A | Pediococcus acidilactici capable of producing various pyrazines and application thereof | 北京工商大学 | 2025-05-06 | — | — | CN | claimed |
| CN-119842550-A | Pediococcus pentosaceus capable of producing various pyrazines and application thereof | 北京工商大学 | 2025-04-18 | — | — | CN | claimed |
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | THE PROCTER & GAMBLE COMPANY (US) | 2014-06-19 | — | — | US | claimed |
| CN-101677582-B | Baked composition | NESTEC SA (CH) | 2012-10-03 | — | — | CN | claimed |
| US-20100233330-A1 | BAKED COMPOSITION | NESTEC S.A. (CH) | 2010-09-16 | — | — | US | claimed |
| EP-2164335-A2 | BAKED COMPOSITION | NESTEC S.A. (CH) | 2010-03-24 | — | — | EP | claimed |
| CN-101677582-A | Baked composition | NESTEC SA (CH) | 2010-03-24 | — | — | CN | claimed |
| WO-2008148737-A2 | BAKED COMPOSITION | NESTEC S.A. (CH) | 2008-12-11 | — | — | WO | claimed |
| EP-2000032-A1 | Baked composition | Nestec S.A. (CH) | 2008-12-10 | — | — | EP | claimed |
| US-7316826-B2 | Coffee aroma with improved stability | SYMRISE GMBH & CO. KG (DE) | 2008-01-08 | — | — | US | claimed |
| US-7288515-B1 | Methods for making clear fragrances and formulations | INFRIN, LLC (US) | 2007-10-30 | — | — | US | claimed |
| US-20040202767-A1 | Coffee aroma with improved stability | SYMRISE AG (DE) | 2004-10-14 | — | — | US | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140170101-A1 | Antiperspirant and Deodorant Compositions | LPO, GPX4, DEK | MAPKAPK2 2581/4885NOS3 18/4885NOS2 19/4885 |
| US-20260007144-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, PTGES2, PTGES | MAPKAPK2 2265/4885NOS3 1959/4885NOS2 2073/4885 |
| US-20260096574-A1 | CHOCOLATE REPLICAS PRODUCED FROM INDIVIDUAL COMPONENTS | HAAO, HTR6, SCD | MAPKAPK2 2578/4885NOS3 1555/4885NOS2 2450/4885 |
| US-20260096585-A1 | ORAL COMPOSITION | TAS2R5, TAS2R16, TAS2R45 | MAPKAPK2 2774/4885NOS3 3580/4885NOS2 4111/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.